Results 11 to 20 of about 11,119 (184)
Varenicline in the treatment of tobacco dependence
Neuropsychiatric Disease and Treatment, 2008 Karl Fagerström1, John Hughes21Smokers Information Centre, Fagerström Consulting AB, Berga Alle 1, 25452 Helsingborg, Sweden; 2University of Vermont, Burlington, Vermont, USAAbstract: Varenicline, a partial agonist of α4& ...
Karl Fagerström, John Hughes
doaj +1 more source
VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? [PDF]
Рациональная фармакотерапия в кардиологии, 2015 The problem of varenicline use in patients with cardiovascular diseases is discussed. Results of large clinical trials and meta-analyses with varenicline have proven its high efficacy for treatment of nicotine addiction in adults and a small number of ...
Yu. V. Lukina, S. Yu. Martsevich
doaj +4 more sources
Evaluation of the cardiovascular effects of varenicline in rats
Drug Design, Development and Therapy, 2015 Engin Burak Selçuk,1 Meltem Sungu,2 Hakan Parlakpinar,3 Necip Ermiş,4 Elif Taslıdere,5 Nigar Vardı,5 Murat Yalçinsoy,6 Mustafa Sagır,3 Alaaddin Polat,7 Mehmet Karatas,8 Burcu Kayhan-Tetik11Department of Family Medicine, 2Inonu University ...
Selçuk EB +10 more
doaj +1 more source
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
Patient Preference and Adherence, 2010 Jon O Ebbert, Kirk D Wyatt, J Taylor Hays, Eric W Klee, Richard D HurtMayo Clinic College of Medicine, Rochester, MN, USAAbstract: Smoking is the leading preventable cause of morbidity and mortality in the US, and decreasing smoking prevalence is a ...
Jon O Ebbert +3 more
doaj +1 more source
Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial [PDF]
Tobacco Induced Diseases, 2016 Introduction Varenicline is an effective smoking cessation medication. Some concern has been raised that its use may precipitate adverse cardiovascular events although no patho-physiological mechanism potentially underlying such an effect has been ...
Helge Haarmann +7 more
doaj +3 more sources
PLoS ONE, 2020 IntroductionVarenicline tartrate is superior for smoking cessation to other tobacco cessation therapies by 52 weeks, in the outpatient setting. We aimed to evaluate the long-term (104 week) efficacy following a standard course of inpatient-initiated ...
Kristin V Carson-Chahhoud +12 more
doaj +2 more sources
Nicotine dependence and neuropsychotic effects of varenicline [PDF]
Безопасность и риск фармакотерапии, 2018 Varenicline is a partial agonist of nicotinic acetylcholine receptors for the therapy of nicotine addiction. The efficacy and safety of the use of varenicline in the treatment of nicotine dependence have been demonstrated in clinical trial EAGLES.
T. M. Bukatina +4 more
doaj +2 more sources
Smoking cessation: an economic analysis and review of varenicline
ClinicoEconomics and Outcomes Research, 2009 Michele A FaulknerCreighton University School of Pharmacy and Health Professions, Omaha, NE, USAAbstract: Despite efforts to decrease tobacco use, smoking continues to be a leading cause of preventable morbidity and premature death.
Michele A Faulkner
doaj +1 more source
BMC Public HealthBackground Adhering to varenicline has been shown to significantly improve the chances of successfully quitting smoking, with studies indicating a twofold increase in 6-month quit rates.
Nadia Minian +9 more
doaj +2 more sources
Visual hallucinations associated with varenicline: a case report [PDF]
Journal of Medical Case Reports, 2009 Introduction Varenicline is widely used for smoking cessation. It has shown efficacy over placebo and bupropion in manufacturer-sponsored trials. Those with mental illness were excluded from these trials.
Raidoo B Mahendri, Kutscher Eric C
doaj +3 more sources